ArticleIrish journal of medical science2026
Comparison of HACOR score and ROX index for predicting noninvasive ventilation failure in acute hypoxemic respiratory failure: a prospective study.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute hypoxemic respiratory failure (AHRF) is commonly managed with noninvasive ventilation (NIV) in the emergency department (ED), but delayed identification of NIV failure worsens outcomes. We compared the HACOR (Heart rate, Acidosis, Consciousness, Oxygenation, and Respiratory rate) score and the ROX (Respiratory rate-OXygenation) index for predicting NIV failure in ED patients with AHRF.
methodsThis prospective observational study enrolled adult patients with AHRF receiving NIV in the ED between December 2024 and December 2025. HACOR and ROX were calculated at baseline and 1 h post-NIV; score changes (ΔHACOR, ΔROX) were also assessed. The primary outcome was NIV failure requiring intubation within 24 h. Predictive performance was evaluated via receiver operating characteristic (ROC) curves and DeLong comparisons.
resultsAmong 127 patients, 66 (52.0%) failed NIV. Non-survivors/failures had significantly worse scores at both timepoints. The 1-hour HACOR showed the highest discriminative ability (AUC 0.878, 95% CI 0.808-0.930), outperforming baseline HACOR, all ROX parameters, and ΔROX (all p ≤ 0.05). A cut-off > 5 yielded 96.7% sensitivity and a negative likelihood ratio of 0.05.
conclusionsIn ED patients with AHRF treated with NIV, the 1-hour HACOR score was superior to all ROX-based metrics for predicting NIV failure. Early HACOR reassessment may enable timely escalation of respiratory support and improve clinical decision-making.
Indexed as
Identifiers
42853470What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.